EP Patent

EP0929301A2 — Controlled release dosage form of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2]oct-3-yl)acetonitrile monohydrochloride

Assigned to SmithKline Beecham Ltd · Expires 1999-07-21 · 27y expired

What this patent protects

A controlled release formulation of an acetonitrile compound and its use in the treatment and/or prophylaxis of certain disorders.

USPTO Abstract

A controlled release formulation of an acetonitrile compound and its use in the treatment and/or prophylaxis of certain disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP0929301A2
Jurisdiction
EP
Classification
—
Expires
1999-07-21
Drug substance claim
No
Drug product claim
No
Assignee
SmithKline Beecham Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.